A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine in Healthy Male Volunteers
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 23 Jun 2016 Primary endpoints assessed at 72 hours and 144 hours (previously they were assessed at only 144 hours).
- 21 Mar 2016 New trial record